The J.P. Morgan Health Care Conference is a leading global event that brings together health care industry leaders, innovators, and investors to explore the latest advancements, trends, and opportunities shaping the future of the sector.
The Clinical Trials on Alzheimer’s Disease (CTAD) Conference, established in 2008, has become a cornerstone event in Alzheimer’s disease (AD) clinical research.
The 35th Alzheimer Europe conference “Connecting science and communities: The future of dementia care” was held from 6 to 8 October 2025 in Bologna, Italy.
The RFMASA 2025 conference (Rencontres Franco-Maghrébines sur la Maladie d’Alzheimer et apparentées) is a specialized medical meeting focused on Alzheimer’s disease and related disorders, held in Lausanne, Switzerland.
The Alzheimer’s Association International Conference (AAIC) is the largest international meeting dedicated to advancing dementia science and clinical practice.
By clicking “Continue,” you acknowledge that you are leaving the Anavex Life Sciences website and will be redirected to a third-party website operated by NASDAQ or its affiliates.
Anavex Life Sciences does not own, control, maintain, or endorse the content on third-party websites and is not responsible for their accuracy, completeness, or reliability. Any information available through this link is provided by third parties and does not represent the views, opinions, forecasts, or predictions of Anavex Life Sciences or its management.
The linked content is provided for informational purposes only and does not constitute investment advice or an offer to buy or sell securities. Investors should rely on their own independent judgment and consult professional advisors before making any investment decisions.
